Price Alert

United Therapeutics Corpo... (UTHR)

NASDAQ: UTHR · Real-Time Price · USD

312.86

0.80 (0.26%)

At close: Aug 15, 2025, 3:59 PM

313.13

0.09%

After-hours: Aug 15, 2025, 04:10 PM EDT

United Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Revenue	3.08B	2.99B	2.88B	2.76B	2.62B	2.5B	2.33B	2.2B	2.11B	1.98B	1.94B	1.86B	1.79B	1.77B	1.69B	1.66B	1.59B	1.51B
Cost of Revenue	339.1M	329.3M	309.7M	304.8M	291.8M	278.1M	257.5M	242.4M	209.5M	175.1M	148.7M	127.4M	117.9M	125.4M	122.5M	122.7M	119M	107.7M
Gross Profit	2.74B	2.66B	2.57B	2.45B	2.32B	2.22B	2.07B	1.96B	1.9B	1.81B	1.79B	1.73B	1.67B	1.64B	1.56B	1.53B	1.47B	1.4B
Operating Income	1.45B	1.4B	1.38B	1.28B	1.26B	1.26B	1.18B	1.1B	1.09B	976.1M	979.7M	973.9M	888.3M	908.7M	555.9M	451.4M	443.8M	362.1M
Interest Income	201.5M	196.4M	199.1M	200.8M	196.3M	187.3M	162.7M	132.5M	100.5M	70.1M	45.2M	28.6M	19.1M	16.3M	16.7M	17.5M	20.1M	23.3M
Pretax Income	1.62B	1.56B	1.54B	1.44B	1.4B	1.38B	1.27B	1.16B	1.12B	933.8M	950.6M	912.3M	804.2M	870.1M	593.9M	567.8M	582.4M	499.8M
Net Income	1.24B	1.21B	1.2B	1.11B	1.07B	1.05B	984.8M	899.8M	871.5M	728.3M	727.3M	707.4M	630.8M	687.4M	475.8M	462.4M	470.9M	405.4M
Selling & General & Admin	742.6M	729.4M	703.7M	673.4M	581.8M	534.2M	477.1M	511M	481.8M	493.3M	485M	446.8M	457.5M	428.8M	467M	497.8M	455M	448.1M
Research & Development	520.3M	525.9M	481M	498.6M	479.8M	429.2M	408M	350.5M	331.9M	336.8M	322.9M	311.9M	325M	305.4M	540.1M	583.3M	572.8M	588.2M
Other Expenses	27.7M	6M	6M	n/a	n/a	-600K	-600K	-600K	-600K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-100K	-100K
Operating Expenses	1.29B	1.26B	1.19B	1.17B	1.06B	963.4M	885.1M	861.5M	813.7M	830.1M	807.9M	758.7M	782.5M	734.2M	1.01B	1.08B	1.03B	1.04B
Interest Expense	31.4M	35.7M	42.9M	50.1M	55.6M	58.8M	59.3M	56.5M	50.1M	41.5M	32.4M	24.8M	20.2M	18.7M	18.6M	18.7M	19M	19.9M
Selling & Marketing Expenses	105.3M	99.7M	96.3M	93.4M	93.4M	88.1M	81.8M	80.7M	77.2M	73.2M	70.8M	64.2M	64.2M	65.2M	64.4M	64.8M	60M	55.6M
Cost & Expenses	1.63B	1.59B	1.5B	1.48B	1.35B	1.24B	1.14B	1.1B	1.02B	1.01B	956.6M	886.1M	900.4M	859.6M	1.13B	1.2B	1.15B	1.14B
Income Tax Expense	374.9M	353.2M	343.9M	327M	331.7M	330.5M	289.5M	257.9M	246.9M	205.5M	223.3M	204.9M	173.4M	182.7M	118.1M	105.4M	111.5M	94.4M
Shares Outstanding (Basic)	45.1M	44.9M	45.2M	44.6M	44.4M	47M	47M	46.9M	46.9M	46.3M	45.8M	48.7M	48.1M	47.69M	45.1M	44.9M	44.8M	44.6M
Shares Outstanding (Diluted)	48.3M	48.6M	48.7M	48.4M	47.5M	49.7M	49.8M	49.7M	49.5M	49.6M	49.4M	48.7M	48.1M	47.7M	47.8M	47.6M	47.3M	46.4M
EPS (Basic)	27.71	27.11	26.45	24.33	23.11	22.38	21.06	19.32	18.52	15.40	15.23	14.84	13.55	14.99	10.59	10.32	10.56	9.14
EPS (Diluted)	25.62	25.06	24.60	22.77	21.76	21.15	19.84	18.15	17.68	14.85	15.02	14.70	13.21	14.45	10.03	9.87	10.29	9.05
EBITDA	1.66B	1.56B	1.61B	1.51B	1.43B	1.42B	1.31B	1.18B	1.18B	1.02B	1B	986.4M	873.2M	938.3M	687.4M	585.1M	596.6M	514.1M
EBIT	1.64B	1.54B	1.53B	1.44B	1.37B	1.36B	1.26B	1.13B	1.13B	969.1M	951.4M	935.7M	823M	888.4M	637.5M	534.7M	546.8M	464.1M
Depreciation & Amortization	25.3M	22.9M	72.5M	66.5M	60.7M	54.9M	53.2M	52.7M	52.3M	52.1M	51.3M	50.7M	50.2M	49.9M	49.9M	50.4M	49.8M	50M